Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Invested Capital (2018 - 2025)

Dna X filings provide 8 years of Invested Capital readings, the most recent being -$7.8 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 36.56% to -$7.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$7.8 million, a 36.56% decrease, with the full-year FY2025 number at -$7.8 million, down 36.56% from a year prior.
  • Invested Capital hit -$7.8 million in Q4 2025 for Dna X, down from -$701000.0 in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $23.1 million in Q3 2023 to a low of -$7.8 million in Q4 2025.
  • Median Invested Capital over the past 5 years was $16.4 million (2024), compared with a mean of $12.4 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 203.69% in 2023 and later plummeted 125.48% in 2024.
  • Dna X's Invested Capital stood at $18.8 million in 2021, then rose by 7.53% to $20.2 million in 2022, then increased by 10.78% to $22.4 million in 2023, then plummeted by 125.48% to -$5.7 million in 2024, then plummeted by 36.56% to -$7.8 million in 2025.
  • The last three reported values for Invested Capital were -$7.8 million (Q4 2025), -$701000.0 (Q3 2025), and -$1.3 million (Q2 2025) per Business Quant data.